Companies: 11,075     total market cap: โ‚ฌ132.305 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
BioCryst Pharmaceuticals
BCRX
#4539
Rank
โ‚ฌ2.18 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
8,60ย โ‚ฌ
Share price
1.97%
Change (1 day)
13.25%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚ฌ0.40 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ0.40 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ0.43 B-7.13%
2024-12-31โ‚ฌ0.47 B0.78%
2023-12-31โ‚ฌ0.46 B-8.8%
2022-12-31โ‚ฌ0.51 B-1.27%
2021-12-31โ‚ฌ0.51 B90.84%
2020-12-31โ‚ฌ0.27 B73.92%
2019-12-31โ‚ฌ0.15 B21.9%
2018-12-31โ‚ฌ0.12 B-13.6%
2017-12-31โ‚ฌ0.14 B73.93%
2016-12-31โ‚ฌ85.41 M-23.67%
2015-12-31โ‚ฌ0.11 B-0.56%
2014-12-31โ‚ฌ0.11 B218.06%
2013-12-31โ‚ฌ35.38 M-18.51%
2012-12-31โ‚ฌ43.42 M-31.4%
2011-12-31โ‚ฌ63.3 M-23.07%
2010-12-31โ‚ฌ82.28 M-17.09%
2009-12-31โ‚ฌ99.24 M63.82%
2008-12-31โ‚ฌ60.58 M-38.02%
2007-12-31โ‚ฌ97.74 M88.32%
2006-12-31โ‚ฌ51.9 M-38.05%
2005-12-31โ‚ฌ83.78 M250.03%
2004-12-31โ‚ฌ23.93 M0.13%
2003-12-31โ‚ฌ23.9 M-39.5%
2002-12-31โ‚ฌ39.5 M-40.96%
2001-12-31โ‚ฌ66.91 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
โ‚ฌ49.19 B 12,001.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ72.77 B 17,803.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚ฌ2.77 B 583.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ2.56 B 530.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.91 B 124.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.44 B 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ7.3 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ24.61 M-93.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ1.27 B 214.16%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com